I’m currently an Associate in the Healthcare Economics and Outcomes Research practice at the Analysis Group, where I support our clients’ pharmacoepidemiology studies and clinical trial development efforts.
Prior to working in consulting, I completed a PhD in Biostatistics at the University of California, Berkeley under the supervision of Sandrine Dudoit. Much of my time in graduate school was spent developing (causal) machine learning methods for high-dimensional data analysis. I also frequently collaborated with epidemiologists, biologists, and clinicians, guiding experimental design and analyzing ‘omic data. My studies and research were supported by scholarships from the Fonds de recherche du Québec – Nature et technologies and the Natural Sciences and Engineering Research Council of Canada.
I also interned for two years in the Data Science Product Development division at Genentech and Roche during my doctoral studies. While there, I developed theory and methods for heterogeneous treatment effect detection and quantification in clinical trials, contributed to open-source software for analyzing data produced by various longitudinal study designs, and evaluated the operating characteristics of phase I oncology trial designs.
PhD in Biostatistics, Designated Emphasis in Computational and Genomic Biology, 2020-2023
University of California, Berkeley
MA in Biostatistics, 2018-2020
University of California, Berkeley
BSc in Honours Statistics, 2016-2018
Concordia University
unihtee implements nonparametric inference procedures for treatment effect modification variable importance parameters. These variable importance parameters reflect individual confounders’ capacity for treatment effect modification and are suited for high-dimensional data with potentially complex correlation structures.
uniCATE implements semiparametric inference procedures for variable importance parameters that assess biomarkers’ treatment effect modification capabilities in high-dimensional clinical trials.
The cvCovEst R package implements a data-adaptive framework for asymptotically optimal covariance matrix estimator selection in high dimensions.
The scPCA R package implements sparse contrastive PCA, a variant of PCA that extracts sparse, stable, and interpretable signal.